Mon, September 16, 2024
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 1, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 1, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 23, 2024
Tue, February 27, 2024
[ 12:00 AM ] - WOPRAI
Wed, November 15, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 8, 2023
[ 12:00 AM ] - WOPRAI
Wed, August 2, 2023
Fri, June 23, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
Mon, March 6, 2023
Thu, February 23, 2023
[ 12:00 AM ] - WOPRAI
Tue, November 29, 2022
[ 12:00 AM ] - WOPRAI
Mon, September 26, 2022
[ 12:00 AM ] - WOPRAI
Tue, August 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 25, 2022
Thu, August 5, 2021
Wed, April 28, 2021
[ 12:00 AM ] - WOPRAI
Fri, February 5, 2021
Tue, November 17, 2020
Fri, November 13, 2020
Tue, September 22, 2020
Thu, August 13, 2020
Wed, June 24, 2020
Mon, May 11, 2020
[ 12:00 AM ] - WOPRAI
Tue, April 7, 2020
Suraj Kalia Initiated (tlsi) at Buy and Held Target at $10 on, Sep 16th, 2024
Suraj Kalia of Oppenheimer, Initiated "TriSalus Life Sciences, Inc." (TLSI) at Buy and Held Target at $10 on, Sep 16th, 2024.
Suraj has made no other calls on TLSI in the last 4 months.
There is 1 other peer that has a rating on TLSI. Out of the 1 peers that are also analyzing TLSI, 0 agree with Suraj's Rating of Hold.
This is the rating of the analyst that currently disagrees with Suraj
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $12 on, Thursday, June 27th, 2024
Contributing Sources